Nika Pharmaceuticals, Inc. (NIKA)

Market Cap	431.19M -55.7%
Revenue (ttm)	n/a
Net Income	-78.13K
EPS	-0.00
Shares Out	1.05B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22
Open	0.4499
Previous Close	0.4100
Day's Range	0.4100 - 0.4499
52-Week Range	0.2000 - 0.9750
Beta	-1.71
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 11, 2026

About Nika Pharmaceuticals

Nika Pharmaceuticals, Inc. engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States. The company offers ITV-1, TNG, physiolong, carotilen, fructin, dry boza, anthocylen C, hypocholestin, biodetoxin, silymaron, and solamentum products. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: NIKA

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 14, 2026

Data Sources Report a data error